CUTR Cutera, Inc. featured news, full reports, and detailed charts
Cutera, Inc. (CUTR) Wrap Up:
We are a global medical device company headquartered in Brisbane, California specializing in the design, development, manufacture, marketing and servicing of laser and other light-based aesthetics systems for practitioners worldwide. We offer easy-to-use products based on three platforms—CoolGlide®, Xeo® and Solera ®—which enable physicians and other qualified practitioners to perform safe and effective aesthetic procedures for their customers. • CoolGlide- Our first product platform, CoolGlide, was launched in March 2000. This product offers laser applications for hair removal, treatment of a range of vascular lesions, including leg and facial veins, and Laser Genesis—a skin rejuvenation procedure that reduces fine lines, reduces pore size and improves skin texture. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f13%2f0001193125-08-055587.html#FIS_BUSINESS"Cutera Inc. (CUTR:NASDAQ)
Snapshot of Cutera Inc. (CUTR)
|
OPEN
$9.00
|
PREVIOUS CLOSE
$9.06
|
|
|
DAY HIGH
$9.24
|
DAY LOW
$8.90
|
|
|
52 WEEK HIGH
12/18/08 - $9.99
|
52 WEEK LOW
03/9/09 - $5.50
|
|
|
MARKET CAP
121.8M
|
AVERAGE VOLUME 3 mo
39.1K
|
|
|
DILUTED EPS TTM
$-1.34
|
SHARES OUTSTANDING
13.4M
|
|
|
CUTR Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
CUTR Top Compensated Officers
Executives, Board Directors
Key developments for Cutera Inc. (CUTR)
Cutera Inc. expected to Report Fiscal Year 2009 Results on February 8, 2010. This event was calculated by Capital IQ (Created on November 3, 2009).
Cutera Inc. reported unaudited consolidated earnings results for the third quarter ended September 30, 2009. For the quarter, the company reported net loss of $13,494,000 or $1.01 per diluted share on net revenues of $12,171,000 against net loss of $2,753,000 or $0.22 per diluted share on net revenues of $19,110,000 for the same period a year ago. Net cash used in operating activities was $146,000 compared to net cash provided by operating activities of $2,869,000 for the same period a year ago. The company reported loss from operations of $1,656,000 and loss before income taxes of $1,368,000 compared to loss from operations of $1,200,000 and loss before income taxes of $2,839,000 for the same period a year ago.
Cutera Inc., Q3 2009 Earnings Call, Nov-02 2009
CUTR Competitors
| Company | Last | Change |
| Cynosure Inc | $10.06 USD | +0.07 |
| IRIDEX Corp | $2.79 USD | +0.01 |
| Palomar Medical Technologies Inc | $8.99 USD | -0.09 |
| Solta Medical Inc | $2.24 USD | -0.03 |
| Syneron Medical Ltd | $10.21 USD | -0.06 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | CUTR | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 2.2x |
|
| Price/Book | 1.2x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 0.4x |
|
|
CUTR |
||
CUTR transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||